Since 2012, AbbVie has gained $49 billion in revenue from price hikes on Humira, a drug for rheumatoid arthritis and other inflammatory diseases. — The pharmaceutical industry has long argued that high drug prices are a good thing because the profits from these price hikes allow companies to spend more on research and development to discover and launch the cures of the future. To test the claim that higher drug prices drive innovation, we…